← Product Code [ODY](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/ODY) · K063048 # TRANS-CATHETER EXTRACTOR (K063048) _Tran Pa-C, Inc. · ODY · Sep 14, 2007 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/ODY/K063048 ## Device Facts - **Applicant:** Tran Pa-C, Inc. - **Product Code:** [ODY](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/ODY.md) - **Decision Date:** Sep 14, 2007 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.5970 - **Device Class:** Class 2 - **Review Panel:** General Hospital ## Indications for Use The Trans Catheter Extractor is a catheter accessory device intended for minimally invasive removal of tunneled long term catheters. The Trans Catheter Extractor is indicated for use with tunneled, double lumen Permcath catheters with cuff sizes ranging from 10.8 french to 14.5 french. ## Device Story Trans Catheter Extractor is a mechanical accessory device for removal of tunneled long-term catheters. Used by clinicians in a clinical setting to facilitate minimally invasive extraction of double lumen Permcath catheters (10.8F-14.5F). Device functions as a mechanical tool to assist in the removal process; no electronic or software components. Benefits include reduced invasiveness during catheter removal procedures. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Mechanical catheter accessory device. No electronic components, software, or energy sources. Materials and dimensions are specific to the mechanical extraction of 10.8F to 14.5F tunneled catheters. ## Regulatory Identification A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design. ## Special Controls *Classification.* Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.” ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird symbol, with three curved lines representing the wings or feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the bird symbol. Public Health Service SEP 1 4 2007 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Tom Tran President/CEO TRAN PA-C. Incorporated 3348 Herringridge Drive Orlando, Florida 32812 Re: K063048 Trade/Device Name: Trans Catheter Extractor Regulation Number: 880.5970 Regulation Name: Percutaneous, Implanted Long-Term Intravascular Catheter Regulatory Class: II Product Code: ODY Dated: August 29, 2007 Received: September 6, 2007 Dear Mr. Tran: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Page 2 - Mr. Tran Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours. Clare Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ Indications for Use of __ 1 ______________________________________________________________________________________________________________________________________________________________________ Page 1 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- 510(k) Number (if known): K063048 Device Name: Trans Catheter Extractor The Trans Catheter Extractor is a catheter accessory device intended for minimally invasive removal of tunneled long term catheters. The Trans Catheter Extractor is indicated for use with tunneled, double lumen Permcath catheters with cuff sizes ranging from 10.8 french to 14.5 french. Prescription Use X (Per 21 CFR 801 Subpart D) OR Over-The Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) 6222 lalon Sign-Off) 1 (1 a mallon of Anesthesiology, General Devices 510{%} Humber:_K�63 04 8 --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/ODY/K063048](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/ODY/K063048) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com